Fig. 3
From: Exploring the potential role of GyrA inhibiting quinoline analog: an in silico study
Frontier molecular orbital (HOMO-LUMO) and molecular electrostatic potential diagram of control and lead compounds from DFT simulation analysis using GaussView v6.1.166. (a) Ciprofloxacin (CIP), (b) Levofloxacin (LEV), (c) M2, (d) M9, (e) M11.
